Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
70
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?26
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study24
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study22
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries20
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System17
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation16
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination15
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model15
The Mini-TRH Test13
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety13
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study12
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not10
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse9
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS8
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA8
8
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation7
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control7
7
News on the Role of Antidepressants in and for COVID-19 and Long COVID7
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response7
Patient and Physician Exposure to Artificial Intelligence Hype6
6
Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting6
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie6
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy6
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey5
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factor5
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case5
5
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis5
5
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use4
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab4
4
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita4
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorde4
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes4
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials4
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis4
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review3
3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?3
Overview: Chronic Pain and Cannabis-Based Medicines3
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs3
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics3
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges2
Metformin is Protective Against the Development of Mood Disorders2
2
2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
How valid are therapeutic reference ranges for psychotropic drugs?2
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye2
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others2
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy2
0.31587290763855